Related Experiment Videos

The management of polycythaemia in the newborn infant

Early Human Development
|December 1, 1980
PubMed

Insights

Partial plasma exchange transfusion for newborn polycythaemia with hyperviscosity may not benefit well infants. Clinical signs increased in exchanged infants, suggesting conservative management for mild cases.

Area of Science:

  • Neonatal Medicine
  • Pediatric Hematology

Background:

  • Management of polycythaemia with hyperviscosity in neonates is not well-defined.
  • Clinical outcomes for well newborns with minor signs of hyperviscosity require further investigation.

Purpose of the Study:

  • To evaluate the efficacy of partial plasma exchange transfusion in neonates with polycythaemia and hyperviscosity.
  • To compare clinical outcomes between exchanged and non-exchanged hyperviscous infants and normal controls.

Main Methods:

  • Randomized controlled trial involving 49 neonates with polycythaemia and hyperviscosity.
  • Intervention group received partial plasma exchange transfusion; control group remained hyperviscous.
  • Comparison with normal control infants for clinical signs, behavioral testing, and neurological development at 8 months.

Main Results:

  • Exchanged infants showed more frequent clinical signs, including one case of necrotizing enterocolitis.
  • Hyperviscous infants exhibited plethoric lungs (41%), abnormal ECGs (12%), hypocalcaemia (9%), and hypomagnesaemia (30%).
  • Behavioral testing revealed differences compared to controls, with poorer scores in the exchange group; neurological and developmental outcomes at 8 months were normal across groups.

Conclusions:

  • Partial plasma exchange transfusion may not offer benefits for well neonates with polycythaemia and hyperviscosity.
  • Conservative management might be appropriate for clinically stable newborns with minor signs of hyperviscosity.
  • Further research is needed to optimize management strategies for neonatal polycythaemia.

Related Concept Videos